Corporate calendar for Janux Therapeutics, Inc. (JANX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.18 | $557M |
| 2026-09-14 | $144M | |
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 |
Price
| Price | $16.25 |
| Market Cap | $991M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ABCL · BHVN · CLDX · HRMY · IMNM · MAZE · NUVB
Explore sector: Healthcare · Biotechnology
More sections of JANX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks